DE3466215D1 - The use of melatonin for the manufacture of a medicament - Google Patents
The use of melatonin for the manufacture of a medicamentInfo
- Publication number
- DE3466215D1 DE3466215D1 DE8484303369T DE3466215T DE3466215D1 DE 3466215 D1 DE3466215 D1 DE 3466215D1 DE 8484303369 T DE8484303369 T DE 8484303369T DE 3466215 T DE3466215 T DE 3466215T DE 3466215 D1 DE3466215 D1 DE 3466215D1
- Authority
- DE
- Germany
- Prior art keywords
- melatonin
- medicament
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPF941883 | 1983-05-18 | ||
AUPG473484 | 1984-04-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3466215D1 true DE3466215D1 (en) | 1987-10-22 |
Family
ID=25642659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8484303369T Expired DE3466215D1 (en) | 1983-05-18 | 1984-05-17 | The use of melatonin for the manufacture of a medicament |
Country Status (4)
Country | Link |
---|---|
US (1) | US4665086A (de) |
EP (1) | EP0126630B1 (de) |
DE (1) | DE3466215D1 (de) |
HK (1) | HK66888A (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU601736B2 (en) * | 1986-05-23 | 1990-09-20 | Sanofi Sante Nutrition Animale Sa | Coated veterinary implants |
US5629310A (en) * | 1986-09-23 | 1997-05-13 | Sterling; William R. | Low dose temazepam |
US5030632A (en) * | 1986-09-23 | 1991-07-09 | Sandoz Pharm. Corp. | Low dose temazepam |
US5211954A (en) * | 1986-09-23 | 1993-05-18 | Sandoz Ltd. | Low dose temazepam |
US5163426A (en) * | 1987-06-26 | 1992-11-17 | Brigham And Women's Hospital | Assessment and modification of a subject's endogenous circadian cycle |
US5167228A (en) * | 1987-06-26 | 1992-12-01 | Brigham And Women's Hospital | Assessment and modification of endogenous circadian phase and amplitude |
US5545192A (en) * | 1987-06-26 | 1996-08-13 | Brigham And Women's Hospital | Intermittent use of bright light to modify the circadian phase |
US5006985A (en) * | 1988-07-15 | 1991-04-09 | Kinetic Software, Inc. | Computer system for minimizing body dysfunctions induced by jet travel or shift work |
US4945103A (en) * | 1989-01-17 | 1990-07-31 | Michael Cohen | Method of treating pre-menstrual syndrome |
US5707652A (en) * | 1990-12-04 | 1998-01-13 | State Of Oregon | Methods of treating circadian rhythm phase disorders |
US6638963B1 (en) | 1990-12-04 | 2003-10-28 | Oregon Health And Science University | Methods for treating circadian rhythm disorders |
US5242941A (en) * | 1990-12-04 | 1993-09-07 | State Of Oregon | Methods of treating circadian rhythm disorders |
US5591768A (en) * | 1990-12-04 | 1997-01-07 | State Of Oregan, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University | Methods for treating circadian rhythm phase disturbances |
US5140562A (en) * | 1991-03-13 | 1992-08-18 | Moore Ede Martin C | Biological timepiece |
DE69229490T2 (de) * | 1991-05-09 | 2000-02-17 | Neurim Pharmaceuticals (1991) Ltd., Tel Aviv | Melatonin enthaltende Arzneimittel |
IT1251544B (it) * | 1991-05-13 | 1995-05-17 | Gabriele Biella | Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico |
ZA928011B (en) * | 1991-10-18 | 1993-06-23 | Alza Corp | Transdermal administration of melatonin. |
IT1255199B (it) * | 1992-07-01 | 1995-10-20 | Franco Fraschini | Farmaco sintetizzato analogo della melatonina particolarmente efficacenelle patologie che interferiscono con i ritmi circadiani |
US5449683A (en) * | 1992-10-01 | 1995-09-12 | Massachussetts Institute Of Technology | Methods of inducing sleep using melatonin |
US5696128A (en) * | 1994-07-07 | 1997-12-09 | The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College | Method of regulating immune function |
AU7550994A (en) * | 1993-07-26 | 1995-02-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University | Sustained release oral compositions containing melatonin |
US6180657B1 (en) | 1993-11-18 | 2001-01-30 | Eli Lilly And Company | Melatonin derivatives for use in treating desynchronization disorders |
US5654325A (en) * | 1993-11-18 | 1997-08-05 | Eli Lilly And Company | Melatonin derivatives for use in treating sleep disorders |
WO1997012612A1 (en) * | 1995-10-03 | 1997-04-10 | Interneuron Pharmaceuticals, Inc. | Compositions of melatonin and analgetic agents and methods of use thereof |
US6274615B1 (en) | 1998-03-25 | 2001-08-14 | South Alabama Medical Science Foundation | Method for delaying the onset of alheimer's disease and for treatment or delaying the onset of other amyloidosis-related diseases/disorders |
US6133453A (en) * | 1998-05-15 | 2000-10-17 | Pharm-Eco Laboratories, Inc. | Method for making substituted indoles |
IL144900A (en) * | 2001-08-14 | 2013-12-31 | Neurim Pharma 1991 | Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs |
US6703412B1 (en) * | 2002-09-27 | 2004-03-09 | Holly A. Rosenthal | Method of treating sleeplessness with melatonin on an acute basis |
EP2028937B2 (de) * | 2006-05-22 | 2018-06-27 | Vanda Pharmaceuticals Inc. | Behandlung mit melatoninagonisten |
CN101516255A (zh) * | 2006-09-13 | 2009-08-26 | 皇家飞利浦电子股份有限公司 | 用于自动调整褪黑素的剂量和/或递送褪黑素的装置 |
WO2010012789A1 (en) * | 2008-07-30 | 2010-02-04 | Ferrer Internacional S. A. | 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds |
CA2753897A1 (en) * | 2009-03-20 | 2010-09-23 | The Salk Institute For Biological Studies | Methods for modulating metabolic and circadian rhythms |
JP2012521364A (ja) * | 2009-03-20 | 2012-09-13 | ザ ソーク インスティテュート フォー バイオロジカル スタディーズ | 概日リズムを調整する方法 |
US8691275B2 (en) | 2011-01-28 | 2014-04-08 | Zx Pharma, Llc | Controlled-release melatonin compositions and related methods |
US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
BR112014018429A8 (pt) | 2012-01-26 | 2017-07-11 | Vanda Pharmaceuticals Inc | Método para tratar um paciente que sofre de não-24, e, método para o tratamento crônico de não-24 em uma pessoa que está totalmente cega |
AU2013361459A1 (en) | 2012-12-18 | 2015-07-02 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
US10376487B2 (en) | 2013-11-12 | 2019-08-13 | Vanda Pharmaceuticals Inc. | Method of treatment |
US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
-
1984
- 1984-05-17 DE DE8484303369T patent/DE3466215D1/de not_active Expired
- 1984-05-17 EP EP84303369A patent/EP0126630B1/de not_active Expired
-
1985
- 1985-09-26 US US06/780,337 patent/US4665086A/en not_active Expired - Lifetime
-
1988
- 1988-08-25 HK HK668/88A patent/HK66888A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK66888A (en) | 1988-09-02 |
EP0126630B1 (de) | 1987-09-16 |
EP0126630A1 (de) | 1984-11-28 |
US4665086A (en) | 1987-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3466215D1 (en) | The use of melatonin for the manufacture of a medicament | |
GB8325529D0 (en) | Medicinal forms | |
ZA848375B (en) | Medicament formulation | |
EP0072251A3 (en) | Improved bandage containing a medicament | |
AU90762S (en) | Inhaler | |
GB8306666D0 (en) | Therapeutic agents | |
GB8324313D0 (en) | Anaesthetic vaporiseur | |
DE3369641D1 (en) | Use of a benzoisothiazoline derivative for the manufacture of a medicament against thrombosis and platelet aggregation | |
DE3469898D1 (en) | Therapeutic agents | |
GB2125803B (en) | Medical casts | |
GB8419699D0 (en) | Therapeutic table | |
GB8421574D0 (en) | Monitoring use of medicines | |
PH20528A (en) | 4-substituted-2-azetidinone compounds and medicaments containing the compounds | |
GB8315906D0 (en) | Therapy helmet | |
GB8322470D0 (en) | Therapeutic agents | |
GB8316632D0 (en) | Administering medicaments | |
PT79679A (en) | Process for the preparation of 2-thiocyanato-benzamides having a fungicidal effect | |
GB2162746B (en) | Antiacidotic medicinal agent | |
GB8302666D0 (en) | Drug convertarule | |
GB8334507D0 (en) | Medicine | |
GB8305650D0 (en) | Therapeutic agent | |
GB8311364D0 (en) | Therapeutic agent | |
GB8321649D0 (en) | Pharmaceutical use | |
GB8321801D0 (en) | Pharmaceutical use | |
GB8321648D0 (en) | Pharmaceutical use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: MONASH UNIVERSITY, CLAYTON, VICTORIA, AU CIRCADIAN |